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Abstract
Background: Breast cancer in females and prostate cancer in males are two of the most common
cancers in the United States, and the literature suggests that they share similar features. However,
it is unknown whether the occurrence of these two cancers at the county level in the United States
is correlated. We analyzed Caucasian age-adjusted county level average annual incidence rates for
breast and prostate cancers from the National Cancer Institute and State Cancer Registries to
determine whether there was a spatial correlation between the two conditions and whether the
two cancers had similar spatial patterns.
Results: There was a significant correlation between breast and prostate cancers by county (r =
0.332, p < 0.001). This relationship was more pronounced when we performed a geographically-
weighted regression (GWR) analysis (r = 0.552) adjusting for county unemployment rates. There
was variation in the parameter estimates derived with the GWR; however, the majority of the
estimates indicted a positive association. The strongest relationship between breast and prostate
cancer was in the eastern parts of the Midwest and South, and the Southeastern U.S. We also
observed a north-south pattern for both cancers with our cluster analyses. Clusters of counties
with high cancer incidence rates were more frequently found in the North and clusters of counties
with low incidence rates were predominantly in the South.
Conclusion:  Our analyses suggest breast and prostate cancers cluster spatially. This finding
corroborates other studies that have found these two cancers share similar risk factors. The north-
south distribution observed for both cancers warrants further research to determine what is
driving this spatial pattern.
Background
Breast cancer in females and prostate cancer in males are
two of the most common cancers in the United States.
Besides a sudden spike in the rate of prostate cancer
between 1989 and 1992, attributed to PSA screening [1]
the incidence of both cancers over time has followed a
similar pattern (Figure 1). The overall age-adjusted inci-
dence rate of breast and prostate cancer in 2004 in the U.S.
Published: 29 September 2009
International Journal of Health Geographics 2009, 8:53 doi:10.1186/1476-072X-8-53
Received: 30 May 2009
Accepted: 29 September 2009
This article is available from: http://www.ij-healthgeographics.com/content/8/1/53
© 2009 Mandal et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
Page 2 of 10
(page number not for citation purposes)
was 117.7 and 145.3 per 100,000 people, respectively [2].
Despite the similar national incidence figures for these
cancers there is considerable variation in the rates of both
cancers at the county level. For example, the highest and
lowest incidence rates for breast cancer in 2004 were
345.5 and 29 cases per 100,000, respectively. For prostate
cancer the range was between 346.2 and 44.2 cases per
100,000 [3].
An extensive review by López-otín and Diamandis com-
pared breast and prostate cancers and highlighted several
similar features and characteristics [4]. One of the most
obvious similarities between breast and prostate cancers is
their hormonal regulation. At least some breast and pros-
tate cancer cell types appear to have receptors for a
number of the same steroid hormones (e.g. estrogens,
progesterone, and androgens) and growth hormones,
such as androgen-induced growth factor and keratinocyte
growth factor. The negative impact of high levels of
endogenous sex steroids, and the benefit of low circulat-
ing sex steroids for both breast and prostate cancers is well
documented in the literature [5,6], and suggests that expo-
sure to exogenous hormones (i.e. hormone therapy, con-
traceptives, dietary fats, and environmental endocrine
disruptors) may also have a negative impact on the onset
and progression of these diseases. In fact, anti-estrogens
and anti-androgens are sometimes effective treatments for
breast and prostate cancers, respectively [7].
The patho-physiological mechanisms by which breast and
prostate tumors develop is not well understood, but evi-
dence suggests several independent pathways may exist,
involving different receptors and complex cascades of
events that ultimately culminate in abnormal cell prolifer-
ation. Most often tumors of the breast and prostate
involve epithelial cell types and express similar biochem-
ical markers, which suggests analogous patho-physiolo-
gies [4]. At least one of these common biomarkers-
prostate specific antigen-has been detected in breast and
prostate tumors, and in no other tumors [8].
Some of the main gene alterations associated with breast
cancer (e.g. BRCA1 and BRCA2) have also been found in
some individuals with prostate cancer [9], and the most
U.S. average age-adjusted incidence rates for breast and prostate cancer from 1975 to 2005 Figure 1
U.S. average age-adjusted incidence rates for breast and prostate cancer from 1975 to 2005. Data were obtained 
from the National Cancer Institute-Surveillance, Epidemiology and End Results.International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
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commonly identified gene alteration in prostate cancer
patients (e.g. alterations in the AR gene) has been detected
in breast cancer patients [10]. The similarity in the genetic
component of these two cancers suggests they share simi-
lar patho-physiological mechanisms. Another link
between these two cancers is the epidemiological studies,
which suggest individuals from families with a high inci-
dence of breast cancer are more likely to develop prostate
cancer and vice versa [11]. Interestingly, genetics accounts
for about 5% of both breast and prostate cancer cases [12].
Epidemiological studies have also identified similar pro-
tective factors for both breast and prostate cancers. In the
last 17 years vitamin D has received a great deal of atten-
tion as an important compound for both breast and pros-
tate cancer prevention [13-16]. It is suggested that the
active form of vitamin D, 1,25(OH)2D regulates transcrip-
tion in cells with vitamin D receptors including breast and
prostate cells [17].
These two types of cancers share many similarities, but
their spatial distributions have not been compared. If they
are homologous cancers they should occur in similar
areas at similar rates. The objective of our study was to
determine whether these two cancers are spatially corre-
lated.
Results
Breast cancer clusters
The Getis-Ord Gi* analysis suggests there were statistically
signifcant clusters of counties with high incidence rates of
breast cancer ("hot" clusters) in the Northeast, Midwest
and northern and mid Pacific West regions (Figure 2). A
medium size hot cluster occurred in the Southeast region,
and a small cluster occurred in the northern part of the
South region (Figure 2). The latter may have been an
extension of the hot cluster in the Midwest had there not
been missing data in that region (Figure 2).
"Cold" clusters (or areas where the incidence of breast
cancer was relatively low) occurred predominantly in the
South (Figure 2). There was only one small cold cluster in
the northern Midwest (Figure 2).
Prostate cancer clusters
Overall, the incidence rate of prostate cancer also had a
north-south distribution with the North having a high
incidence of prostate cancer and the South having coun-
ties with a lower incidence rate, with one exception in
Louisiana and Mississippi (Figure 3). There were large
clusters of counties with a high incidence rate of prostate
cancer in the Northeast, northern and western parts of the
Midwest, northern part of the Mountain West regions,
and the eastern part of the South region (Figure 3).
There was a large area where counties had a lower inci-
dence of prostate cancer than expected. This area spanned
the southern part of the Midwest and northern part of the
South and Southeast regions (Figure 3). There were small
to medium-sized cold clusters that also occurred in the
southern parts of the Mountain West and South regions.
For the most part there was a north-south distribution to
both types of cancers; however, the hot and cold clusters
for these cancers did not always overlap. Shared geo-
graphic clusters with high incidence rates of breast and
prostate cancers occurred in the Northeast and Midwest
(Figures 2 and 3). Common areas of cold clusters for both
cancers were found in the South, parts of the Southeast
region, and southern parts of the Mountain West region
(Figures 2 and 3). The north-south distribution for both
cancers was observed regardless of the band distance used
in the Getis-Ord Gi* cluster analysis.
Correlations
The least squares correlation coefficient for the dataset on
Caucasians with breast and prostate cancer was 0.332. The
correlation coefficient for breast and prostate cancers for
the smaller subset of data for all races was 0.336 (Table 1).
The latter coefficient was higher than the coefficients with
the other cancers and breast and prostate cancers (r was
always less than 0.149; Table 1).
The correlation coefficient from the unemployment-
adjusted geographically-weighted regression (GWR) anal-
ysis for breast and prostate cancer incidence rates for Cau-
casians was 0.552, which suggests a stronger correlation
between the two cancers when information from the sur-
rounding counties was taken into account. There were
only 26 out of 2651 (1.0%) counties that had standard-
ized residuals greater than or less than 3 standard devia-
tions from the mean. This was only slightly above what is
expected from normal variation suggesting the regression
model fit the data well. Further, the counties with these
more extreme residual values appeared to be dispersed at
random throughout the U.S.
The standardized county-level parameter estimates from
the GWR were mostly positive (97.6%), which indicates a
positive association between breast and prostate for most
counties. Further, the negative standardized parameters
were not statistically significant (i.e. not less than -2 stand-
ard deviations from the mean), and 76.2% of the positive
values were significant (i.e. greater than 2 standard devia-
tions from the mean). The pattern obtained by mapping
the standardized parameter estimate suggests the strong-
est relationship between breast and prostate cancer was in
the eastern parts the Midwest and South, and in the
Southeastern U.S. (Figure 4).International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
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Discussion
We determined, using county-level data from the NCI,
that the annual age-adjusted incidence rates of breast and
prostate cancer in the U.S. between 2000/2001 and 2004/
2005 were correlated at the county level (Table 1 and Fig-
ure 4). In general, counties with a high incidence of breast
cancer also had a high incidence of prostate cancer, and
vice versa. The correlation coefficient between these two
cancers was greater than the correlation coefficient
between these cancers and other cancers that are not hor-
monally regulated (Table 1), suggesting that risk factors
for both breast and prostate cancers either cluster together
spatially or the two cancers share common risk factors.
The correlation between these cancers increased from
0.332 to 0.552 when we used a geographically-weighted
regression model, which accounted for data within a 200
km radius. This sudden increase in the correlation coeffi-
cient suggests similar risk factors for these cancers at a geo-
graphical area greater than the county level. These results
also suggest our county level correlation is unlikely to be
due to the county's cancer detection and reporting system.
Geographical clusters of U.S. counties with significant high or low breast cancer incidence rates among Caucasians (including  Hispanics) analyzed at a 200 km distance band Figure 2
Geographical clusters of U.S. counties with significant high or low breast cancer incidence rates among Cauca-
sians (including Hispanics) analyzed at a 200 km distance band. The graduated red and blue colors show high (hot) 
and low (cold) clusters respectively, for age-adjusted average annual incidence rates (2000/2001-2004/2005) of breast cancer. 
The counties with no color either have no data or counts less than 3-5. Graduated colors were assigned to the hot and cold 
clusters based on the incidence rate of individual counties. In total there were 2,692 counties used in the breast cancer cluster 
analysis. The inserted regional U.S. map depicts the regions of the U.S. used to describe the cluster patterns. Data source: 
National Cancer Institute-State Cancer Profiles and State Cancer Registries.International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
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The parameter estimates calculated for each county in our
geographically-weighted regression model indicated over
76% of the counties had a significant positive association
between breast and prostate cancer. This relationship var-
ied across the U.S. and was strongest in the eastern area of
the Midwest and adjacent areas of the Southeast and
Southern U.S (Figure 4). The areas, where the standard-
ized parameter estimates were the highest, were often
where the hot and cold clusters for breast and prostate
cancers overlapped (Figures 2, 3, and 4). There were only
a few areas where the parameter estimates suggested a neg-
ative correlation between breast and prostate cancer, and
these values were not statistically significant (i.e. blue
areas in Figure 4). For the most part, our data suggested
the rates for both of these cancers were positively corre-
lated. This study identifies counties, as well as larger geo-
graphic areas within the U.S. where this correlation is
strongest and weakest, which is useful for further research
into potential factors driving the incidence of these can-
cers.
Both cancers also had a distinct north-south distribution
(Figures 2 and 3), with the exception of the area known as
"cancer alley" in the states of Louisiana and Mississippi
[18]. In general, areas with higher than expected incidence
of cancer (hot clusters) were located in the northern states
and areas with lower than expected incidence of cancer
(cold clusters) were in the southern states. This trend has
also been reported by Schwartz and Hanchette [19] for
prostate cancer mortality rates in the U.S. A U.S.-wide spa-
Geographical clusters of U.S. counties with significant high or low prostate cancer incidence rates among Caucasians (including  Hispanics) analyzed at a 200 km distance band Figure 3
Geographical clusters of U.S. counties with significant high or low prostate cancer incidence rates among Cau-
casians (including Hispanics) analyzed at a 200 km distance band. The graduated red and blue colors show high (hot) 
and low (cold) clusters respectively, for age-adjusted average annual incidence rates (2000/2001-2004/2005) of prostate can-
cer. The counties with no color are those with either no data or counts less than 3-5. Graduated colors were assigned to the 
hot and cold clusters based on the incidence rate for counties. In total there were 2,777 counties used in the prostate cancer 
cluster analysis. Data source: National Cancer Institute-State Cancer Profiles and State Cancer Registries.International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
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tial analysis has not been reported for breast cancer; how-
ever, there have been reports of higher occurrence of
breast cancer mortality in the northeastern U.S. than the
southeastern part of the country [20,21].
There are several possible explanations for the north-
south pattern of breast and prostate cancers. One explana-
tion proposed by several researchers is the low exposure to
ultraviolet radiation (UV) in the northern states, espe-
cially during the winter months [19,22], which is believed
to result in lower vitamin D levels [19]. There are several
independent researchers who have experimentally docu-
mented the beneficial effects of vitamin D on differentia-
tion and proliferation for cell types with vitamin D
receptors such as prostate and breast cells [23,24]. There
are also several epidemiological studies that have exam-
ined UV exposure as a modifying factor for breast and
prostate cancers and found a protective effect [19,24].
Another risk factor that may contribute to the clustering of
cancer in the North may be low temperature, which
almost always confounds UV exposure. That is, areas with
a high UV index generally have high temperature and
those with a low UV index have lower temperature. Tem-
perature has a significant effect on ecological processes.
Experiments have demonstrated that the biodegradation
of certain organic compounds, including endocrine dis-
ruptors and chelation of heavy metals, is temperature-
dependant and slower at colder temperatures [25,26]. It is
also documented that semi-volatile organic chemicals
(i.e. PCBs) precipitate out of the atmosphere more effi-
ciently at cold temperatures and during snow events [27-
32]. There may, therefore, be an interaction between pre-
cipitation, temperature, and atmospheric pollution, and
exposure to endocrine disruptors, which have been asso-
ciated with an increase in risk of both breast and prostate
cancer [6,33,34], may be greater at higher altitudes and
latitudes. This phenomenon would occur on a global
scale and may explain the higher incidence of cancers at
higher latitudes that have been reported in numerous
countries [24].
There are also other differences in the distribution of risk
and protective factors across the U.S. that may partially
explain the north-south distribution of cancer observed in
this study. For example, cultural differences that increase
or decrease the risk of cancer (i.e. behavior and diets) may
be unevenly distributed between the northern and south-
ern U.S. It is also possible that the rate of other diseases,
such as cardiovascular disease, is higher in the southern
U.S. [35] thereby resulting in premature mortality and
lower incidence of cancer in these areas. Because this
study was an ecological study and data were obtained at
the county level, we could not adjust for differences in
individual risk factors. However, we were able to adjust
for age and race by using Caucasians only and age-
adjusted rates in our analyses. So it is unlikely that age and
race played a significant role in the distribution pattern
observed.
Ethnicity may have contributed to the distribution pattern
as we could not obtain data on Caucasians that were not
of Hispanic origin. Because individuals of Hispanic origin
have lower risks of breast and prostate cancers [2], and the
distribution of individuals that are of Hispanic origin is
not even throughout the continental U.S., this factor may
Table 1: Correlation coefficients for regression analyses between different types of cancers.
Cancer types Correlation (r) Number of counties Race/Ethnicity P Value
Breast Prostate 0.332 2651a Caucasians & Hispanics < 0.001
Breast Prostate 0.336 2205 b All races < 0.001
Breast Colon/Rectum 0.139 1804 b All races < 0.001
Breast Lung/Bronchus 0.149 1845 b All races < 0.001
Breast Ovary 0.106 801 b All races 0.003
Prostate Lung/Bronchus -0.018 2070 b All races 0.41
Prostate Colon/Rectum 0.124 1859 b All races < 0.001
Ordinary least square regressions analyses were conducted on age-adjusted (to the 2000 U.S. standard population) county level average incidence 
rates (cases per 100,000 population per year) for different types of cancers. Data used in these analyses were extracted from the National Cancer 
Institute (NCI) and State Cancer Registries.
aData from counties in all states were included for the period between 2000 (or 2001) and 2004 (or 2005).
b Data from counties in all states except Illinois, Maryland, Minnesota, Mississippi, North Dakota, Tennessee and Virginia were included for the 
period between 2000 (or 2001) and 2004.International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
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have contributed to the north-south distribution pattern.
However, it is unlikely that this factor was the only reason
for the north-south distribution because other researchers
have noted a similar pattern in other countries [24].
Socioeconomic status is a known risk factor for many can-
cers and their outcome. To minimize the effect of this var-
iable on our outcome of interest we used incidence data
instead of mortality data. Although socioeconomic status
is associated with the detection of cancer, it is most likely
less dependent on the availability of adequate health care
than mortality rates, which is strongly influenced by the
treatment received by the patient. We also corrected for
this variable in our GWR model by including the county's
average annual unemployment rate between 2001 and
2004. Despite this, it is still possible that this parameter
biased the findings of the correlation and influenced the
cluster analyses. However, the fact that other types of can-
cers were not as strongly correlated with breast and pros-
tate cancers at the county level (Table 1) suggests breast
and prostate cancers are correlated (i.e. counties with high
incidence rates of breast cancer also tend to have a high
incidence rate of prostate cancer and vice versa) regardless
of the effect of socioeconomic status.
County level standardized parameter estimates from a geographically-weighted regression, analyzed at a 200 km distance band  comparing age-adjusted average annual incidence rates (2000/2001-2004/2005) of breast and prostate cancers adjusting for the  county unemployment rate Figure 4
County level standardized parameter estimates from a geographically-weighted regression, analyzed at a 200 
km distance band comparing age-adjusted average annual incidence rates (2000/2001-2004/2005) of breast and 
prostate cancers adjusting for the county unemployment rate. In total there were 2651 counties included in the anal-
ysis. The counties with no color are those with either no data or counts less than 3-5. Counties depicted in orange and red 
indicate statistically significant positive parameter estimates (i.e. positive relationship between the two cancers). Data sources: 
National Cancer Institute-State Cancer Profiles and State Cancer Registries and USDA Economic Research Service. (Std Stand-
ard).International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
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One other possible bias in this study was the disparity in
the size of the counties within the continental U.S. In gen-
eral, the counties in the east were much smaller than those
in the west, which may have affected our cluster analyses.
Because the predominant pattern observed was north to
south, and this pattern was consistent using different dis-
tances to measure clusters (data not shown), we felt that
the east to west variation in the size of individual counties
most likely did not affect our overall conclusions. Further,
the north-south disease pattern observed in this study is
consistent with other research that has found a relation-
ship between latitude and breast and prostate cancers in
other areas of the world [24].
There were a few inconsistencies in the spatial distribution
and correlation between breast and prostate cancers. For
example, there was a small cluster of counties in the south
known as "cancer alley" that had a high incidence of pros-
tate cancer, but did not have higher than expected breast
cancer rates. Similarly, there were a few clusters of coun-
ties with a high incidence of breast cancer in the southeast
that did not coincide with elevated prostate cancer (Figure
2 and 3). The variation in the parameter estimates from
our GWR analysis also suggests the relationship between
these cancers varies and, therefore they may not be com-
pletely homologous. If we had refined our case definition
and only included specific types of breast or prostate can-
cers that are more likely to be analogous (i.e. similar cell
types and responsive to specific types of steroid hor-
mones), the distribution may have overlapped better. Fur-
ther, the aggregation of data at the county level renders it
impossible to analyze information at a smaller spatial
scale. The reason we used county level data is because it
was age-adjusted, averaged over several years, and readily
available for the entire U.S.
There are multiple factors that may act synergistically on
prostate and breast cell types, while others may act antag-
onistically on these tissues [4,6], which may account for
some of the inconsistencies in the distribution of the two
types of cancers. Risk factors for these cancers may also
not be equally distributed within the male and female
populations in a county. Despite the differences in the dis-
tribution of these cancers, the distinct north-south spatial
pattern and the positive correlation between the cancers
warrants further investigation to identify the factors driv-
ing these patterns. A model that includes variables such as
socioeconomic status, incidence of other diseases, tem-
perature, precipitation, pollution and UV indices, and
controls for ethnicity would provide insight into the epi-
demiology of breast and prostate cancers. The findings of
this study add to the growing evidence in the literature
that prostate and breast cancers have similar risk factors
and patho-physiological mechanisms.
Methods
Spatial cluster analyses for individual cancers
We extracted age-adjusted (to the 2000 U.S. standard pop-
ulation) annual incidence rates (cases per 100,000 popu-
lation per year) for breast and prostate cancer between
2000 and 2004 or 2001 and 2005 from the National Can-
cer Institute (NCI) website [3], for each county in the
United States for Caucasians and Caucasians of Hispanic
origin. All data from the NCI website originate from indi-
vidual State Cancer Registries. Analyses were only per-
formed on data for Caucasians (of Hispanic and non-
Hispanic origin combined) with the exception of data
from counties in Illinois. The data for this state were only
available for all races combined; therefore, we only
included the data from counties where more than 95% of
the population was Caucasian. We assumed the rates were
representative of Caucasians in these cases. Rates for pros-
tate and breast cancer were only for invasive cancers (not
in situ). We excluded counties with average annual counts
of less than 3-5 from the analysis because stable accurate
age-adjusted rates were not available for these counties.
For six states, including Illinois (2001-2005), Maryland
(2000), Minnesota (2000-2004), Mississippi (2003-
2005), Tennessee (1999-2003) and Virginia (2000-2004),
we obtained data from individual State Cancer Registry
websites, as their data were not available through the NCI.
The time block used to calculate the average annual age-
adjusted incidence rate varied slightly by states (i.e. 2000-
2004 or 2001-2005, and in one case 1999-2003).
We assessed the cancer data from the continental United
States for spatial clustering using the Getis-Ord Gi* Arc-
GIS (v 9.3). All counties with missing data were removed
for this analysis. We used the fixed distance band of 200
km in the Getis-Ord Gi* cluster analysis for breast and
prostate cancers. This distance was selected based on the
autocorrelation detected using a semivariance analysis
[36] (data not shown) and the Getis-Ord Gi* analysis
algorithm criterion of at least 1 county and preferably 8-
10 counties for reliable results. All counties with signifi-
cant Z scores (e.g. values ≥ 1.96 and ≤ -1.96) were identi-
fied. Negative values represented counties where there
were 200 km radius clusters of lower than expected cancer
incidence rates and high Z scores indicated counties where
there were higher than expected cancer incidence rates
within a 200 km radius. We also ran the Getis-Ord Gi*
analysis using a distance band of 300 km and 400 km for
comparison. We used the regions of the U.S. depicted in
Figure 2 to describe the cluster patterns. All maps were
generated in ArcGIS (v 9.3).
Spatial correlation between breast and prostate cancer
Two methods were used to assess the spatial correlation
between the incidence rates of breast and prostate cancers.International Journal of Health Geographics 2009, 8:53 http://www.ij-healthgeographics.com/content/8/1/53
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First, we used an ordinary least square regression model to
determine if there was a correlation between breast and
prostate cancers at the county level. Second, we used a
geographically-weighted regression analysis to determine
if there was correlation between the incidence rates of
these two cancers at the county level after adjusting for
local, spatially-structured variation.
Ordinary least square regression analyses (OLS)
We used the dataset described above to assess whether
counties with a high incidence of breast cancer also had a
high incidence of prostate cancer and vice versa. The
regression analyses were conducted in Minitab (v 15.1).
Assumptions of parametric tests were tested using regres-
sion diagnostics.
For comparison, correlations between these two cancers
and lung and bronchial, colon and rectal, ovarian, and
testicular cancers were also calculated. The data on these
cancers were extracted in a similar manner with the excep-
tion that all races were included in the calculations and
the seven states that did not provide data to the NCI were
excluded. To ensure an appropriate comparison we also
extracted breast and prostate cancer incidence rates from
these same states for all races. Regression analyses were
conducted as described above.
Geographically-weighted regression analyses (GWR)
We tested for and found spatial autocorrelation in the
incidence of breast and prostate cancers among counties
using a semivariance analysis [36], and concluded that
incidence rates in nearby counties were more likely to be
similar than among counties separated by greater dis-
tances. Our Getis-Ord Gi* cluster analyses also supported
this finding. To evaluate the correlation between breast
and prostate cancers accounting for data in surrounding
counties, we conducted a geographically-weighted regres-
sion analysis using ArcGIS (v 9.3) [37] adjusting for
county average annual unemployment rates between
2001 and 2004. The unemployment rates were obtained
from the United States Department of Agriculture Eco-
nomic Research Service [38]. Specifically, a fixed kernel
type function with a 200 km bandwidth parameter was
used to calculate the GWR regression coefficients. Stand-
ardized residuals greater than 3 standard deviations above
and below the mean were identified. The parameter esti-
mates, derived for each county were divided by their
standard errors, creating standardized t statistics. These
values were mapped in ArcGIS (v 9.3). The analysis was
done using the same dataset used for the spatial clustering
analysis on Caucasians, which included individuals of
Hispanic origin.
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